True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History,Merged_Grouping_1,Merged_Grouping_2,Merged_Grouping_3,Score,Scoring_Reasoning
"cd8-positive, alpha-beta t cell",Cytotoxic Lymphocyte,"CD8+ T Cells, Gamma Delta (γδ) T Cells, Natural Killer (NK) Cells","CD8+ Cytotoxic T Lymphocytes, CD8+ Gamma Delta T Cells",50,"KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,,"Final Annotation Agent: Okay, let's analyze this list of highly expressed markers from a single-cell cluster in human large intestine tissue to identify the cell type.

**Step 1: List the Key Functional Markers**

Here are some key functional markers from the list and their roles:

*   **GZMH, GZMA, GZMB, GZMK, GZMM:** These are Granzymes, serine proteases found in the granules of cytotoxic lymphocytes (like NK cells and cytotoxic T cells). They are crucial for inducing apoptosis in target cells. Their presence strongly suggests a cytotoxic function.
*   **PRF1:** Perforin, a protein also found in cytotoxic granules. It forms pores in the membrane of target cells, allowing granzymes to enter and initiate apoptosis. This further supports a cytotoxic role.
*   **XCL1, XCL2, CCL4, CCL4L2, CCL5:** These are Chemokines. XCL1 and XCL2 are lymphotactins, attracting lymphocytes. CCL4 (MIP-1β), CCL4L2, and CCL5 (RANTES) are inflammatory chemokines that recruit various immune cells, including T cells, NK cells, and macrophages, to sites of inflammation. Their expression indicates the cells are involved in immune signaling and recruitment.
*   **IFNG:** Interferon-gamma, a potent cytokine produced by T cells and NK cells. It plays a critical role in innate and adaptive immunity, activating macrophages, increasing MHC class I expression, and promoting Th1 differentiation. Its presence points towards an active immune response.
*   **NKG7:** Natural Killer Cell Granule Protein 7, a transmembrane protein found in the granules of NK cells and cytotoxic T lymphocytes. Its function is not fully elucidated but is associated with cytotoxic activity.
*   **CTSW:** Cathepsin W, a cysteine protease found in cytotoxic lymphocytes. It is involved in processing granzymes and other granule proteins.
*   **CST7:** Cystatin F, a cysteine protease inhibitor. Its role in cytotoxic lymphocytes is not fully understood but may be involved in regulating protease activity.
*   **TIGIT, LAG3:** These are immune checkpoint receptors. TIGIT (T cell immunoreceptor with Ig and ITIM domains) and LAG3 (Lymphocyte-activation gene 3) are inhibitory receptors expressed on T cells and NK cells. Their expression can indicate a state of exhaustion or regulation of the immune response.
*   **TNFRSF9 (4-1BB):** Tumor necrosis factor receptor superfamily member 9, a costimulatory receptor expressed on activated T cells and NK cells. Ligation of 4-1BB enhances proliferation, survival, and cytotoxic function. Its presence suggests activation.
*   **CD160:** Cluster of Differentiation 160, a receptor expressed on NK cells, T cells, and other immune cells. It can have both inhibitory and activating functions depending on the context.
*   **ENTPD1 (CD39):** Ectonucleoside triphosphate diphosphohydrolase 1, an enzyme that hydrolyzes ATP and ADP to AMP. Expressed on regulatory T cells and other immune cells, it is involved in purinergic signaling and can contribute to immunosuppression. Its presence here is interesting given the other cytotoxic markers.
*   **PTPN22:** Protein Tyrosine Phosphatase Non-Receptor Type 22, a phosphatase involved in regulating T cell signaling. Mutations in PTPN22 are associated with autoimmune diseases.
*   **SH2D1A:** SH2 Domain Containing 1A, also known as SAP (SLAM-associated protein). It is a crucial adaptor protein involved in signaling through the SLAM family receptors, important for T cell and NK cell activation and function. Mutations in SH2D1A cause X-linked lymphoproliferative disease.

**Step 2: List the Key Cell Type Markers**

Here are some key cell type markers from the list and their roles:

*   **CD8A, CD8B:** These are subunits of the CD8 co-receptor, which is typically expressed on cytotoxic T lymphocytes (CTLs) and a subset of NK cells. CD8 binds to MHC class I molecules on target cells, enhancing T cell receptor signaling and cytotoxic activity. The presence of both CD8A and CD8B strongly points towards CD8+ T cells.
*   **KLRK1 (NKG2D), KLRC2 (NKG2C), KLRC4 (NKG2E), KLRD1 (CD94):** These are Killer Cell Lectin-like Receptors. NKG2D is an activating receptor expressed on NK cells, CD8+ T cells, and γδ T cells, recognizing stress-induced ligands on target cells. NKG2C, NKG2E, and CD94 form heterodimers with NKG2A (not on the list) and are expressed on NK cells and some T cell subsets. CD94/NKG2A is typically inhibitory, while CD94/NKG2C and CD94/NKG2E can be activating. Their presence suggests either NK cells or specific subsets of T cells.
*   **CRTAM:** Class I-restricted T cell-associated molecule, a receptor expressed on activated CD8+ T cells and NK cells. It is involved in cell-cell adhesion and signaling.
*   **TRGC1, TRGC2:** These are genes encoding the constant regions of the T cell receptor gamma chain. Their presence indicates the expression of gamma delta (γδ) T cell receptors. γδ T cells are a distinct lineage of T cells that play roles in innate and adaptive immunity, particularly at mucosal surfaces like the intestine.
*   **CD7:** Cluster of Differentiation 7, a transmembrane protein expressed on T cells, NK cells, and hematopoietic stem cells. It is a pan-T cell marker but also found on NK cells.
*   **GPR18:** G protein-coupled receptor 18, a receptor for oxysterols. Its expression has been associated with specific immune cell subsets, including some T cell populations.
*   **TMIGD2 (CD28H):** Transmembrane and immunoglobulin domain containing 2, a costimulatory molecule expressed on T cells and NK cells. It interacts with B7-H7 (B7x) and promotes T cell activation.
*   **HOPX:** Homeodomain Only Protein X, a transcriptional regulator. Its expression has been observed in various cell types, including some immune cells, and its role can be context-dependent.
*   **ZEB2:** Zinc Finger E-box Binding Homeobox 2, a transcriptional repressor involved in epithelial-mesenchymal transition and immune cell development and function. Its expression in immune cells can be associated with specific differentiation states.
*   **IKZF2 (Helios):** Ikaros Family Zinc Finger 2, a transcription factor. Helios is often expressed in regulatory T cells (Tregs) but can also be found in activated conventional T cells and other immune cells. Its presence here, alongside cytotoxic markers, is notable and might suggest a specific subset or activation state.

**Step 3: Cross-reference Known Databases**

Cross-referencing these markers with scRNA-seq databases (like the Human Cell Atlas, PanglaoDB, CellMarker) and relevant literature on intestinal immunity reveals strong associations with cytotoxic lymphocytes. The co-expression of Granzymes, Perforin, CD8A/B, and various Killer Cell Lectin-like Receptors is a hallmark of cytotoxic T cells and NK cells. The presence of TRGC1/TRGC2 is a key indicator of γδ T cells. The expression of chemokines and IFNG further supports an immune cell identity involved in inflammatory responses.

**Step 4: Determine the Most Probable General Cell Type**

Based on the overwhelming presence of cytotoxic granule proteins (Granzymes, Perforin), cytotoxic co-receptors (CD8A/B), and receptors associated with cytotoxicity and immune activation (KLRs, CRTAM, TNFRSF9), the most probable general cell type is **Cytotoxic Lymphocyte**.

**Step 5: Identify the Top 3 Most Probable Sub Cell Types**

Now, let's refine the annotation based on the specific markers:

1.  **CD8+ T Cells:** The strong expression of CD8A and CD8B is a primary characteristic of cytotoxic T lymphocytes (CTLs). The presence of Granzymes, Perforin, IFNG, and costimulatory molecules like TNFRSF9 aligns perfectly with the function of activated CTLs. Many of the KLRs (like NKG2D) are also expressed on CD8+ T cells.
2.  **Gamma Delta (γδ) T Cells:** The clear expression of TRGC1 and TRGC2 is definitive for γδ T cells. γδ T cells are abundant in mucosal tissues like the intestine and can exhibit cytotoxic activity, expressing Granzymes and Perforin. Some γδ T cell subsets also express CD8. The presence of KLRs is also consistent with γδ T cells.
3.  **Natural Killer (NK) Cells:** NK cells are another major type of cytotoxic lymphocyte. They express many of the same cytotoxic markers (Granzymes, Perforin, NKG7, IFNG, chemokines) and KLRs (NKG2D, CD94/NKG2C/E). However, the prominent expression of CD8A/B and TRGC1/TRGC2 makes NK cells less likely as the primary population, although a subset of NK cells can express CD8.

Considering the high expression of CD8A/B and the presence of TRGC1/TRGC2 alongside the cytotoxic machinery, this cluster likely represents a mix or a specific subset of cytotoxic T lymphocytes. The co-expression of CD8 and γδ TCR is known to occur in certain γδ T cell subsets, particularly in mucosal tissues.

Therefore, the top three most probable sub cell types, ranked from most likely to least likely, are:

1.  **CD8+ T Cells (specifically Cytotoxic T Lymphocytes)**
2.  **Gamma Delta (γδ) T Cells (potentially CD8+ subsets)**
3.  **Natural Killer (NK) Cells (less likely as the dominant population due to CD8 and TRGC expression)**

Based on the combined evidence, particularly the strong expression of CD8A/B and the cytotoxic markers, the most likely specific subtype is **CD8+ Cytotoxic T Lymphocytes**, with a significant possibility of including a population of **CD8+ Gamma Delta T Cells** given the TRGC expression. It's possible this cluster represents a heterogeneous population of cytotoxic T cells.

**Step 6: Provide a Concise Summary of Your Analysis**

This single-cell cluster from human large intestine tissue is characterized by high expression of genes associated with cytotoxicity, immune signaling, and specific lymphocyte lineages. Key functional markers include Granzymes (GZMH, GZMA, GZMB, GZMK, GZMM), Perforin (PRF1), chemokines (XCL1, XCL2, CCL4, CCL5), and IFNG, indicating a cytotoxic and inflammatory role. Key cell type markers include CD8A/B, Killer Cell Lectin-like Receptors (KLRK1, KLRC2, KLRC4, KLRD1), and T cell receptor gamma chain constant regions (TRGC1, TRGC2). The strong expression of CD8A/B, Granzymes, and Perforin points towards a cytotoxic T lymphocyte identity. The presence of TRGC1/TRGC2 indicates the inclusion of γδ T cells, potentially CD8+ subsets. Cross-referencing with databases confirms this marker profile is consistent with cytotoxic lymphocytes found in mucosal tissues. The most probable general cell type is Cytotoxic Lymphocyte. The top three most probable sub cell types are CD8+ T Cells, Gamma Delta (γδ) T Cells, and Natural Killer (NK) Cells. Based on the prominent CD8A/B and cytotoxic marker expression, the most likely specific subtype is **CD8+ Cytotoxic T Lymphocytes**, potentially including CD8+ γδ T cells.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""Cytotoxic Lymphocyte"",
  ""sub_cell_types"": [
    ""CD8+ T Cells"",
    ""Gamma Delta (\u03b3\u03b4) T Cells"",
    ""Natural Killer (NK) Cells""
  ],
  ""possible_mixed_cell_types"": [
    ""CD8+ Cytotoxic T Lymphocytes"",
    ""CD8+ Gamma Delta T Cells""
  ],
  ""num_markers"": 50
}",T cells,CD8+ T cells,CD8+ cytotoxic T cells,92,"The annotation results demonstrate a thorough and scientifically accurate analysis of the marker list, effectively identifying the cell type as a cytotoxic lymphocyte. The analysis correctly highlights key markers such as CD8A/B, granzymes (GZMA, GZMB, etc.), perforin (PRF1), and chemokines (CCL4, CCL5), which are hallmark features of cytotoxic T cells and NK cells. The inclusion of TRGC1/TRGC2 as indicators of γδ T cells is particularly insightful, as these markers are often overlooked but are critical for identifying this subset in mucosal tissues like the large intestine.

Strengths:
1. **Comprehensive Marker Analysis**: The annotation considers a wide range of markers, balancing functional (e.g., cytotoxic proteins) and lineage-specific markers (e.g., CD8A/B, TRGC1/2). This avoids over-reliance on a single marker and captures the heterogeneity of the population.
2. **Contextual Relevance**: The analysis acknowledges the tissue origin (human large intestine) and aligns the marker profile with known immune cell subsets in mucosal tissues, such as CD8+ T cells and γδ T cells.
3. **Ranking of Subtypes**: The annotation logically ranks the most probable sub-cell types (CD8+ T cells > γδ T cells > NK cells), reflecting the relative strength of the evidence for each. The consideration of potential mixed populations (e.g., CD8+ γδ T cells) adds nuance.

Weaknesses:
1. **NK Cell Likelihood**: While NK cells are mentioned, the analysis could further justify why they are less likely (e.g., CD8A/B is rare in NK cells, and TRGC1/2 are absent). This would strengthen the exclusion of NK cells as the dominant population.
2. **Regulatory Markers**: The presence of markers like ENTPD1 (CD39) and IKZF2 (Helios) is noted but not deeply explored. These could hint at regulatory or exhausted subsets within the cytotoxic population, which might be relevant in the intestinal context.
3. **Marker Rank Consideration**: The analysis does not explicitly discuss the rank or expression level of markers (e.g., KLRC2 appears first but is not prioritized over CD8A/B). While the final conclusion is correct, this could add another layer of validation.

Overall, the annotation provides a comprehensive and accurate view of the cell population, with minor room for deeper exploration of regulatory/exhausted subsets and marker rank. The conclusion aligns well with the data and current understanding of intestinal immune cells."
intestinal crypt stem cell,Intestinal Stem Cells,"LGR5+ Intestinal Stem Cells, Early Progenitor Cells (Transit-Amplifying Cells), Secretory Precursor Cells",,50,"AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,,"Final Annotation Agent: Okay, let's analyze this list of markers to identify the cell type from human large intestine tissue.

**Step 1: List the Key Functional Markers**

Looking through the provided list, several genes stand out as potentially having functional roles relevant to intestinal cells:

*   **IGFBPL1 (Insulin-like growth factor-binding protein-like 1):** While not a direct functional marker of a specific process, IGFBPL1 is known to be expressed in various tissues, including the intestine, and can interact with IGFs, which are involved in cell growth and differentiation. Its presence suggests a role in cellular proliferation or maintenance.
*   **LGR5 (Leucine-rich repeat-containing G protein-coupled receptor 5):** This is a highly significant marker. LGR5 is a well-established marker of intestinal stem cells and other stem cell populations in various tissues. It is a receptor for R-spondins, which are crucial for Wnt signaling, a pathway essential for stem cell maintenance and proliferation in the intestine.
*   **TDGF1 (Teratocarcinoma-derived growth factor 1):** Also known as Cripto-1, TDGF1 is a growth factor that plays a role in embryonic development and stem cell maintenance. It is involved in Nodal and Wnt signaling pathways, both important for intestinal development and stem cell function.
*   **ASCL2 (Achaete-scute family BHLH transcription factor 2):** ASCL2 is a transcription factor that is a key regulator of intestinal stem cell identity and proliferation. It is a direct target of Wnt signaling and is essential for maintaining the LGR5+ stem cell population.
*   **SLC39A2 (Solute carrier family 39 member 2):** This gene encodes a zinc transporter. While zinc transport is a general cellular function, specific transporters can be enriched in certain cell types and play roles in their specific functions or maintenance. Its presence here might be related to the metabolic needs of the identified cell type.

**Step 2: List the Key Cell Type Markers**

Based on the functional markers identified above, the most prominent cell type markers in this list are:

*   **LGR5:** As mentioned, this is a canonical marker for intestinal stem cells. Its high expression is a strong indicator of this cell type.
*   **TDGF1:** While also having functional roles, its expression is often associated with stem cell populations, including intestinal stem cells.
*   **ASCL2:** This transcription factor is a critical marker and regulator of intestinal stem cells.

Several other genes in the list appear to be ribosomal proteins (e.g., RPL7P54, RPL41P1, RPL41P5, RPL9P21, RPL21P16, RPL7P6), pseudogenes (indicated by ""P"" in the name, e.g., HMGN2P6, CHCHD2P9, PPIAP40, EIF5AP4, COX5AP2, NPM1P6, PPIAP11, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, PPIAP29, HNRNPA1P4, PPIAP31, HMGN1P36, HMGN2P41, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, KRT8P13, RPSAP15, HMGN1P38, RPSAP8), or uncharacterized loci (e.g., AL031284.1, AC012085.1, AC010132.3, AC008694.2, AC092670.1, AC090498.1, AL162151.2, AC016596.2, AL603825.1, AC005884.2, AL035411.1, AF279873.1, AC112491.1, AC022968.1). The high expression of ribosomal proteins is often indicative of actively proliferating cells, which is consistent with stem cell populations. The presence of pseudogenes and uncharacterized loci in a ranked list of highly expressed genes can sometimes be due to technical artifacts or their proximity to highly expressed genes, but their functional or cell-type specificity is generally low compared to well-established markers.

**Step 3: Cross-reference Known Databases**

Cross-referencing LGR5, TDGF1, and ASCL2 with scRNA-seq databases and literature on the human large intestine consistently identifies these genes as key markers of intestinal stem cells located at the base of the crypts. Databases like the Human Cell Atlas and numerous publications on intestinal epithelial cell differentiation confirm the strong association of these markers with the stem cell compartment. The co-expression of these genes is a hallmark of actively cycling and self-renewing intestinal stem cells.

**Step 4: Determine the Most Probable General Cell Type**

Based on the strong and consistent expression of LGR5, TDGF1, and ASCL2, the most probable general cell type for this cluster is **Intestinal Stem Cells**.

**Step 5: Identify the Top 3 Most Probable Sub Cell Types**

Within the general category of Intestinal Stem Cells, there can be some subtle distinctions or states. Based on the provided markers, it's challenging to definitively distinguish between very fine subtypes without additional markers or context. However, we can consider potential states or closely related populations:

1.  **LGR5+ Intestinal Stem Cells:** This is the most direct and well-supported annotation based on the key markers. These are the actively cycling, multipotent stem cells responsible for regenerating the intestinal epithelium.
2.  **Early Progenitor Cells (Transit-Amplifying Cells):** While LGR5 expression is highest in stem cells, some early progenitor cells that are rapidly dividing and moving up the crypt can still express some level of LGR5, ASCL2, and TDGF1, although typically at lower levels than the true stem cells. The high expression of ribosomal proteins could also be consistent with these rapidly proliferating cells.
3.  **Secretory Precursor Cells:** Some studies suggest that LGR5+ stem cells can directly give rise to secretory lineage precursors (like goblet or enteroendocrine cells) without going through a distinct transit-amplifying stage. While the provided markers don't strongly point to a specific secretory lineage, the multipotency of LGR5+ cells means this is a possible differentiation trajectory. However, without markers of specific secretory lineages (e.g., MUC2 for goblet cells, CHGA for enteroendocrine cells), this is less likely to be the primary identity of the cluster compared to the core stem cell population.

Based on the strong expression of the canonical stem cell markers LGR5, TDGF1, and ASCL2, the most likely subtype is **LGR5+ Intestinal Stem Cells**.

**Step 6: Provide a Concise Summary of Your Analysis**

The analysis of the provided marker list, particularly the high expression of LGR5, TDGF1, and ASCL2, strongly indicates that this cell cluster represents Intestinal Stem Cells from the human large intestine. These genes are well-established markers and regulators of the intestinal stem cell population responsible for epithelial regeneration. The presence of highly expressed ribosomal proteins is consistent with the actively proliferating nature of these cells. Cross-referencing with existing databases and literature confirms this annotation. The most probable general cell type is Intestinal Stem Cells, and the most likely specific subtype is LGR5+ Intestinal Stem Cells.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""Intestinal Stem Cells"",
  ""sub_cell_types"": [
    ""LGR5+ Intestinal Stem Cells"",
    ""Early Progenitor Cells (Transit-Amplifying Cells)"",
    ""Secretory Precursor Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}",Epithelial cells,Intestinal stem cells,LGR5+ intestinal stem cells,85,"The annotation results demonstrate a strong understanding of the key markers for intestinal stem cells, particularly highlighting LGR5, TDGF1, and ASCL2, which are well-established markers for this cell type. The analysis correctly identifies these genes as central to the annotation and provides a scientifically accurate conclusion that the cluster represents LGR5+ Intestinal Stem Cells. The inclusion of ribosomal proteins and pseudogenes in the context of actively proliferating cells is also appropriate, as these are often associated with stem cell populations.

Strengths:
1. **Correctness of Annotations**: The primary annotation of ""Intestinal Stem Cells"" is highly accurate, supported by robust markers like LGR5, TDGF1, and ASCL2. These are widely recognized in the literature and databases such as the Human Cell Atlas.
2. **Balanced Consideration of Markers**: The analysis does not overly rely on a single marker but integrates multiple markers (LGR5, TDGF1, ASCL2) to strengthen the annotation. It also acknowledges the role of ribosomal proteins and pseudogenes, though their functional relevance is lower.
3. **Comprehensive View**: The annotation provides a clear general picture of the cell population, including potential subtypes (e.g., Early Progenitor Cells, Secretory Precursor Cells), though these are less strongly supported by the provided markers.

Weaknesses:
1. **Overemphasis on Pseudogenes and Ribosomal Proteins**: While these are noted, their inclusion in the top markers list might distract from the more functionally relevant markers. The analysis could have more explicitly downplayed their significance in cell type identification.
2. **Subtype Specificity**: The suggested subtypes (Early Progenitor Cells, Secretory Precursor Cells) are plausible but not strongly supported by the provided markers. The analysis could have been more cautious in proposing these without additional lineage-specific markers.
3. **Marker Rank Consideration**: The analysis does not explicitly discuss the rank of markers (e.g., LGR5 appears third in the list), which could have been used to further validate the primary annotation. Higher-ranked markers (e.g., AL031284.1, AC012085.1) are pseudogenes/uncharacterized loci, which might have warranted more critical evaluation.

Overall, the annotation is scientifically sound and captures the general picture well, but there is room for improvement in handling less relevant markers and subtype specificity."
intestinal enteroendocrine cell,Enteroendocrine cells,"L cells, Enterochromaffin (EC) cells, S cells",L and EC cells,50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,,"Final Annotation Agent: Okay, I will analyze the provided list of highly expressed markers from a single-cell RNA sequencing cluster from human large intestine tissue to identify the cell type.

**Step 1: List the Key Functional Markers**

This cluster shows high expression of several genes encoding hormones, neuropeptides, and enzymes involved in their synthesis and processing, indicating a secretory, likely endocrine, function.

*   **GCG (Glucagon):** While primarily known for its role in glucose regulation from pancreatic alpha cells, GCG is also produced by intestinal L cells and acts as a gut hormone.
*   **PYY (Peptide YY):** A gut hormone produced predominantly by L cells in the ileum and colon, involved in regulating appetite and gut motility.
*   **INSL5 (Insulin-like peptide 5):** Another peptide hormone produced by L cells, implicated in gut motility and appetite regulation.
*   **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone family, found in various endocrine cells, including some enteroendocrine subtypes.
*   **SCT (Secretin):** A gut hormone produced by S cells, primarily in the duodenum and jejunum, stimulating bicarbonate secretion. Its presence here suggests potential S cells or overlap.
*   **PCSK1 (Proprotein convertase subtilisin/kexin type 1):** An enzyme involved in the post-translational processing of prohormones and neuropeptides into their active forms. Highly expressed in neuroendocrine cells.
*   **TPH1 (Tryptophan hydroxylase 1):** The rate-limiting enzyme in the synthesis of serotonin (5-hydroxytryptamine). A key marker for enterochromaffin (EC) cells.
*   **SLC18A1 (Solute carrier family 18 member A1):** Also known as VMAT1 (Vesicular Monoamine Transporter 1), responsible for packaging monoamines like serotonin into vesicles for secretion. Another key marker for EC cells.

**Step 2: List the Key Cell Type Markers**

The marker list includes several genes characteristic of neuroendocrine cells and specific enteroendocrine subtypes, as well as transcription factors involved in their development.

*   **General Neuroendocrine Markers:**
    *   **CHGA (Chromogranin A):** A ubiquitous marker for neuroendocrine cells, involved in the storage and release of hormones and peptides.
    *   **CHGB (Chromogranin B):** Another chromogranin, also a general marker for neuroendocrine cells.
    *   **SCG2 (Secretogranin II), SCG3 (Secretogranin III), SCG5 (Secretogranin V):** Members of the secretogranin family, involved in the processing and storage of hormones and peptides in secretory granules. Common in neuroendocrine cells.
    *   **SNAP25 (Synaptosomal-associated protein 25):** A component of the SNARE complex involved in vesicle fusion and exocytosis, characteristic of neurons and neuroendocrine cells.
    *   **CPLX2 (Complexin 2):** A protein that regulates SNARE-mediated vesicle fusion, found in neuroendocrine cells.
    *   **SCGN (Secretagogin):** A calcium-binding protein found in neuroendocrine cells, potentially involved in calcium-regulated exocytosis.
    *   **PRPH (Peripherin), INA (Internexin neuronal intermediate filament protein alpha):** Intermediate filament proteins found in neurons and some neuroendocrine cells.
*   **Transcription Factors:**
    *   **FEV (FEV transcription factor):** Involved in the development and differentiation of specific enteroendocrine cells, including EC and L cells.
    *   **NKX2-2 (NK2 homeobox 2):** A transcription factor crucial for the development of various endocrine cell types, including enteroendocrine cells.
    *   **INSM1 (Insulinoma-associated protein 1):** A key transcription factor required for the differentiation of neuroendocrine cells.
    *   **RFX6 (Regulatory factor X6):** A transcription factor essential for the development of pancreatic and intestinal endocrine cells.
    *   **ARX (Aristaless related homeobox):** A transcription factor involved in the development of various endocrine cells, including pancreatic alpha cells and intestinal L cells.
*   **Other Potential Markers:**
    *   **LCN15 (Lipocalin 15):** Less commonly cited as a primary enteroendocrine marker, but sometimes associated with gut epithelium.
    *   **SLC5A8 (Solute carrier family 5 member 8):** A sodium-coupled monocarboxylate transporter, found in colonocytes and potentially some enteroendocrine cells, involved in transporting short-chain fatty acids.

**Step 3: Cross-reference Known Databases**

Cross-referencing these markers with established scRNA-seq datasets of the human large intestine (e.g., Human Cell Atlas, specific gut scRNA-seq studies) and relevant literature confirms that the co-expression of general neuroendocrine markers (CHGA, SCG*, PCSK1, INSM1) along with specific hormone/peptide markers (GCG, PYY, INSL5, TPH1, SCT) and transcription factors (FEV, NKX2-2, RFX6, ARX) is characteristic of enteroendocrine cells. The specific combination and ranking of markers point towards particular subtypes.

**Step 4: Determine the Most Probable General Cell Type**

Based on the strong and consistent expression of general neuroendocrine markers (CHGA, CHGB, SCG*, PCSK1, SNAP25, INSM1) and the presence of multiple gut hormones/peptides and their synthesis machinery (GCG, PYY, INSL5, TPH1, SLC18A1, SCT, PCSK1), the most probable general cell type is **Enteroendocrine cells**.

**Step 5: Identify the Top 3 Most Probable Sub Cell Types**

The cluster expresses markers associated with multiple enteroendocrine subtypes. Based on the ranking and specificity of the markers:

1.  **L cells:** High expression of GCG, PYY, and INSL5, which are canonical markers for L cells, particularly abundant in the large intestine. FEV and ARX are also associated with L cell development.
2.  **Enterochromaffin (EC) cells:** High expression of TPH1 and SLC18A1 (VMAT1), which are specific markers for EC cells responsible for serotonin production. FEV is also associated with EC cells.
3.  **S cells:** Expression of SCT, the marker for S cells. While S cells are primarily found in the upper small intestine, they are present at lower frequencies in the large intestine.

Given the very high ranking of L cell markers (GCG, PYY, INSL5) and the significant presence of EC cell markers (TPH1, SLC18A1), this cluster likely represents a population enriched for L cells but also containing or co-expressing markers of EC cells. The presence of SCT suggests a minor contribution from S cells or potential marker overlap/plasticity.

Based on the prominence and ranking of the markers, the most likely subtype is **L cells**, with a significant contribution or overlap from Enterochromaffin (EC) cells.

**Step 6: Provide a Concise Summary of Your Analysis**

This cell cluster from the human large intestine is confidently identified as **Enteroendocrine cells** due to the high expression of general neuroendocrine markers such as CHGA, PCSK1, SCG*, INSM1, and SNAP25. Further analysis of specific hormone and synthesis markers reveals a strong signal for **L cells** (GCG, PYY, INSL5) and a significant signal for **Enterochromaffin (EC) cells** (TPH1, SLC18A1). The presence of SCT suggests a potential minor component of S cells or marker co-expression. Based on the ranking of specific markers, the cluster is most likely composed of **L cells**, potentially with co-expression of EC markers or representing a mixed population of L and EC cells.

FINAL ANNOTATION COMPLETED. | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""Enteroendocrine cells"",
  ""sub_cell_types"": [
    ""L cells"",
    ""Enterochromaffin (EC) cells"",
    ""S cells""
  ],
  ""possible_mixed_cell_types"": [
    ""L and EC cells""
  ],
  ""num_markers"": 50
}",Epithelial cells,Enteroendocrine cells,Enteroendocrine L cells,92,"The annotation results provided are scientifically accurate and well-supported by the markers listed. The analysis correctly identifies the cluster as **Enteroendocrine cells**, which is justified by the presence of general neuroendocrine markers such as **CHGA**, **CHGB**, **SCG family genes**, **PCSK1**, and **INSM1**. The annotation further refines this to specific subtypes, primarily **L cells** (marked by **GCG**, **PYY**, and **INSL5**) and **Enterochromaffin (EC) cells** (marked by **TPH1** and **SLC18A1**), with a minor mention of **S cells** (marked by **SCT**). This aligns with known literature and scRNA-seq datasets for the human large intestine.

**Strengths:**
1. **Comprehensive Marker Analysis:** The annotation considers a wide range of markers, including hormones, neuropeptides, processing enzymes, and transcription factors, providing a holistic view of the cell type. For example, the inclusion of **FEV**, **NKX2-2**, and **RFX6** as transcription factors supports the developmental context of enteroendocrine cells.
2. **Subtype Differentiation:** The annotation distinguishes between L cells and EC cells based on the prominence of their respective markers (e.g., **GCG** for L cells and **TPH1** for EC cells). This is well-reasoned and reflects the heterogeneity within enteroendocrine populations.
3. **Rank Consideration:** The analysis acknowledges the ranking of markers (e.g., **GCG** appearing early in the list), which is critical for interpreting scRNA-seq data where marker expression levels matter.
4. **Validation:** The annotation references cross-referencing with established databases (e.g., Human Cell Atlas), adding credibility to the conclusions.

**Weaknesses:**
1. **Minor Oversight in Subtype Specificity:** While the annotation mentions **S cells**, their primary marker (**SCT**) is less prominent in the large intestine compared to the small intestine. The analysis could have explicitly noted this rarity or potential artifact.
2. **Handling of Mixed Populations:** The annotation suggests a possible mixed population of L and EC cells but does not explore whether this could represent transitional states or technical noise (e.g., doublets). A deeper discussion on this aspect would strengthen the analysis.
3. **Less Common Markers:** Some markers (e.g., **LCN15**, **SLC5A8**) are briefly mentioned but not thoroughly contextualized. While they may not be primary markers, their inclusion without explanation could confuse less experienced readers.

**Overall,** the annotation is highly accurate and captures the general picture of the cell populations effectively. The minor weaknesses do not detract significantly from the overall correctness and utility of the results."
monocyte,Glial cells,"Myelinating Schwann Cells, Non-myelinating (Remak) Schwann Cells, Satellite Glial Cells",,50,"NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,,"Final Annotation Agent: Okay, I will analyze the provided list of highly expressed markers from a single-cell cluster in a human large intestine dataset to identify the cell type.

**Step 1: List the Key Functional Markers**

This cluster expresses several genes related to neural function, cell adhesion, and myelination:

*   **PLP1 (Proteolipid Protein 1):** A major structural component of myelin, essential for the formation and maintenance of the myelin sheath that insulates axons.
*   **SOX10 (SRY-Box Transcription Factor 10):** A transcription factor critical for the development and maintenance of neural crest-derived cells, including glial cells like Schwann cells and oligodendrocytes, and is involved in regulating myelin gene expression.
*   **FOXD3 (Forkhead Box D3):** Another transcription factor involved in neural crest development and the specification of various cell lineages, including glial cells.
*   **L1CAM (L1 Cell Adhesion Molecule):** A cell adhesion molecule involved in neuron-neuron and neuron-glia interactions, neurite outgrowth, and myelination.
*   **NRXN1 (Neurexin 1), NRXN3 (Neurexin 3):** Presynaptic cell adhesion molecules that interact with postsynaptic neuroligins to form synapses. In the context of glia, they are involved in glia-neuron communication and synapse modulation.
*   **CADM2 (Cell Adhesion Molecule 2):** A synaptic cell adhesion molecule involved in synapse formation and maintenance.
*   **SLITRK2 (SLIT and NTRK Like Family Member 2):** A transmembrane protein involved in neuronal development and synapse formation.
*   **CHL1 (Cell Adhesion Molecule L1 Like):** A cell adhesion molecule involved in neuronal development, axon guidance, and myelination.
*   **TENM3 (Teneurin Transmembrane Protein 3):** A transmembrane protein involved in neural circuit assembly and synapse formation.
*   **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** A receptor protein tyrosine phosphatase expressed in the nervous system, involved in neuronal development and glial function, including myelination.
*   **GFRA2 (GDNF Family Receptor Alpha 2):** A receptor for neurturin, involved in the survival and development of various neuronal populations and their associated glia.
*   **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** A transmembrane protein involved in cell adhesion and signaling, expressed in the nervous system.
*   **SPP1 (Secreted Phosphoprotein 1):** Involved in cell adhesion, migration, and immune responses. Can be expressed by Schwann cells in certain states, such as injury or development.

**Step 2: List the Key Cell Type Markers**

The most prominent cell type markers in this list point towards glial cells of the peripheral nervous system:

*   **PLP1:** A canonical marker for myelinating glial cells (oligodendrocytes in CNS, Schwann cells in PNS). Its high expression is a strong indicator of myelination.
*   **SOX10:** A definitive marker for neural crest-derived glial cells, including Schwann cells and satellite glial cells.
*   **FOXD3:** Another marker for neural crest derivatives, including Schwann cells.
*   **L1CAM, NRXN1, NRXN3, CADM2, SLITRK2, CHL1, TENM3, PTPRZ1, GFRA2, FLRT1:** While many of these are involved in neuronal function, their co-expression with PLP1, SOX10, and FOXD3 in the peripheral nervous system context is characteristic of Schwann cells, which intimately interact with axons and form myelin.

**Step 3: Cross-reference Known Databases**

Cross-referencing these markers (especially PLP1, SOX10, FOXD3) in scRNA-seq databases like the Human Cell Atlas, PanglaoDB, and CellMarker, as well as relevant literature on the peripheral nervous system and large intestine innervation, consistently identifies this marker profile with **Schwann cells**. PLP1 is a well-established marker for myelinating Schwann cells. SOX10 and FOXD3 are markers for the broader Schwann cell lineage. The presence of numerous neuron-interaction molecules further supports a cell type closely associated with axons.

**Step 4: Determine the Most Probable General Cell Type**

Based on the strong expression of key glial markers (PLP1, SOX10, FOXD3) and numerous genes involved in neuron-glia interaction and myelination, the most probable general cell type is **Glial cells**, specifically those associated with the peripheral nervous system found within the large intestine tissue.

**Step 5: Identify the Top 3 Most Probable Sub Cell Types**

Within the peripheral nervous system, the main glial cell types are Schwann cells and Satellite glial cells. Schwann cells are further categorized into myelinating and non-myelinating (Remak) Schwann cells.

1.  **Myelinating Schwann Cells:** These cells form the myelin sheath around large caliber axons in the PNS. They are characterized by high expression of myelin structural genes like PLP1, MPZ, and PMP22, as well as transcription factors like SOX10 and FOXD3. The high ranking of **PLP1** in the provided list is a strong indicator of this subtype.
2.  **Non-myelinating (Remak) Schwann Cells:** These cells ensheath multiple small caliber axons but do not form myelin sheaths. They express SOX10 and FOXD3, and neuron-interaction markers, but typically have low or absent expression of myelin structural genes like PLP1.
3.  **Satellite Glial Cells:** These cells surround neuronal cell bodies in ganglia. They express SOX10 and GFAP but are distinct from Schwann cells and do not express myelin markers like PLP1.

Given the high expression of **PLP1**, the most likely subtype is **Myelinating Schwann Cells**.

**Step 6: Provide a Concise Summary of Your Analysis**

The single-cell cluster from the human large intestine dataset is characterized by the high expression of canonical Schwann cell markers, including PLP1, SOX10, and FOXD3. The presence of PLP1, a key component of myelin, strongly indicates a myelinating cell type. Furthermore, the cluster expresses numerous genes involved in neuron-glia adhesion and interaction (e.g., L1CAM, NRXN1, CADM2, PTPRZ1), consistent with the function of Schwann cells in supporting and interacting with peripheral axons. Based on this marker profile, the cluster is confidently identified as **Myelinating Schwann Cells**.

FINAL ANNOTATION COMPLETED. | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""Glial cells"",
  ""sub_cell_types"": [
    ""Myelinating Schwann Cells"",
    ""Non-myelinating (Remak) Schwann Cells"",
    ""Satellite Glial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}",Glial cells,Schwann cells,Myelinating Schwann cells,95,"The annotation results demonstrate a thorough and scientifically accurate analysis of the marker genes, correctly identifying the cluster as glial cells, specifically myelinating Schwann cells. Here’s a detailed evaluation:

### Strengths:
1. **Correctness of Annotations**: The annotation is scientifically sound. Key markers like **PLP1**, **SOX10**, and **FOXD3** are accurately interpreted as indicative of Schwann cells, particularly myelinating Schwann cells. The inclusion of **NRXN1**, **CADM2**, and **L1CAM** further supports the neuron-glia interaction context, which is characteristic of Schwann cells.
2. **Balanced Consideration of Markers**: The analysis does not overly rely on a single marker but integrates multiple markers to build a coherent picture. For example, **PLP1** (myelination) is paired with **SOX10** (glial lineage) and **L1CAM** (neuron-glia interaction), providing a holistic view.
3. **Comprehensive View**: The annotation captures the general cell type (glial cells) and correctly narrows it down to myelinating Schwann cells as the most probable subtype. It also considers alternative subtypes (non-myelinating Schwann cells, satellite glial cells) but justifies the primary annotation with strong evidence.
4. **Rank Consideration**: The analysis implicitly considers marker rank by prioritizing **PLP1**, **SOX10**, and **FOXD3**, which are highly expressed and biologically significant for Schwann cells.

### Weaknesses:
1. **Peripheral vs. Enteric Nervous System Context**: The analysis assumes the glial cells are part of the peripheral nervous system (PNS) but does not explicitly address the possibility of enteric glial cells (EGCs), which are also present in the large intestine. While EGCs share some markers with Schwann cells (e.g., **SOX10**), they typically lack **PLP1**. This oversight is minor but worth noting.
2. **SPP1 Interpretation**: **SPP1** is mentioned as a Schwann cell marker in certain states, but its role in immune responses or other contexts (e.g., fibrosis) is not explored. This could hint at a rare or activated Schwann cell state, but the analysis does not delve deeper.
3. **Lack of Negative Markers**: The analysis does not explicitly rule out other glial subtypes (e.g., oligodendrocytes, which express **PLP1** but are CNS-specific) using negative markers, though the tissue origin (large intestine) makes this unlikely.

### Overall:
The annotation is highly accurate and well-reasoned, with only minor oversights. The strength of the marker evidence and the logical flow of the analysis justify the final annotation."
plasma cell,Plasma Cell,"IgA-secreting Plasma Cells, IgG-secreting Plasma Cells, Plasma Cells",,50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,,"Final Annotation Agent: Okay, I will analyze the provided marker list from the human large intestine scRNA-seq dataset to identify the cell type of this cluster.

**1. List the Key Functional Markers:**

*   **Immunoglobulin Genes (IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MZB1, IGHG3, IGHV3-74, IGHM, IGKV3-20, IGHA2):** This is the most prominent group of markers. These genes encode the components of antibodies (immunoglobulins). The high and diverse expression of both heavy (IGH) and light (IGK, IGL) chain variable (V) and constant (C) regions, including different isotypes (IGHG1, IGHG3 for IgG; IGHA1, IGHA2 for IgA; IGHM for IgM), is a hallmark of cells actively producing and secreting antibodies. JCHAIN encodes the joining chain, which is required for the formation of polymeric immunoglobulins (IgA and IgM). MZB1 is involved in immunoglobulin secretion and ER function.
*   **DERL3, TXNDC5:** These genes are involved in the Endoplasmic Reticulum-Associated Degradation (ERAD) pathway. Cells that produce and secrete large amounts of protein, like antibodies, have highly developed ER systems and associated quality control mechanisms like ERAD. Their expression here supports high protein synthesis and secretion activity.
*   **CCR10:** Chemokine receptor 10. Expression of this receptor is associated with migration to mucosal tissues, including the gut, in various immune cells, notably plasma cells.

**2. List the Key Cell Type Markers:**

*   **TNFRSF17 (BCMA):** Tumor Necrosis Factor Receptor Superfamily Member 17, also known as B-cell maturation antigen (BCMA). This receptor is highly expressed on mature B cells, plasmablasts, and plasma cells and is crucial for their survival.
*   **MZB1:** Marginal zone B and B1 cell-specific protein 1. While initially associated with marginal zone B cells, it is highly upregulated in plasma cells and involved in immunoglobulin secretion.
*   **GPRC5D:** G Protein-Coupled Receptor Family C Group 5 Member D. This receptor is specifically expressed on plasma cells and is a known target in multiple myeloma.
*   **FCRL5:** Fc Receptor Like 5. Expressed on B cells and plasma cells, potentially involved in regulating B cell activation and antibody production.

**3. Cross-reference Known Databases:**

Cross-referencing these markers with databases like the Human Protein Atlas, PanglaoDB, and the CellMarker database confirms that the combination of high immunoglobulin gene expression, TNFRSF17, MZB1, GPRC5D, and CCR10 is highly characteristic of plasma cells. Literature on large intestine scRNA-seq consistently identifies clusters with these markers as plasma cells, particularly IgA-secreting ones, given the mucosal location.

**4. Determine the Most Probable General Cell Type:**

Based on the overwhelming expression of immunoglobulin genes, coupled with specific markers like TNFRSF17, MZB1, GPRC5D, and CCR10, and the presence of genes involved in protein secretion machinery (DERL3, TXNDC5), the most probable general cell type is **Plasma Cell**.

**5. Identify the Top 3 Most Probable Sub Cell Types:**

Considering the general cell type and the specific markers, particularly the immunoglobulin isotypes expressed:

1.  **IgA-secreting Plasma Cells:** The large intestine is a major site of IgA production. The presence of IGHA1 and IGHA2 (IgA heavy chains) among the highly expressed immunoglobulin genes strongly suggests that a significant proportion, if not the majority, of cells in this cluster are committed to producing and secreting IgA. This is the most likely specific subtype in this tissue context.
2.  **IgG-secreting Plasma Cells:** The presence of IGHG1 and IGHG3 (IgG heavy chains) indicates that some cells in this cluster are producing IgG. While IgA is dominant in the gut mucosa, IgG-secreting plasma cells are also present.
3.  **Plasma Cells (Mixed Isotype/Other Isotypes):** The cluster likely contains plasma cells secreting different isotypes (IgA, IgG, IgM as indicated by IGHM) or a mix. While IgA is likely dominant, acknowledging the presence of other isotypes or a general plasma cell population is necessary. Plasmablasts, while related, are less likely to show such a strong secretion signature and high expression of mature plasma cell markers like GPRC5D.

Based on the markers, the most likely specific subtype is **IgA-secreting Plasma Cells**.

**6. Provide a Concise Summary of Your Analysis:**

The analysis of the provided marker list reveals a strong signature of antibody production and secretion. Key markers include a wide array of immunoglobulin heavy and light chain genes (IGH, IGL, IGK), the joining chain (JCHAIN), and proteins involved in antibody secretion (MZB1) and ER function (DERL3, TXNDC5). Furthermore, the cluster expresses canonical plasma cell markers such as TNFRSF17 (BCMA), GPRC5D, and CCR10, which is associated with mucosal homing. Given the tissue origin (large intestine, a mucosal site) and the prominent expression of IGHA1 and IGHA2, this cluster is most consistent with **Plasma Cells**, predominantly **IgA-secreting Plasma Cells**.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""Plasma Cell"",
  ""sub_cell_types"": [
    ""IgA-secreting Plasma Cells"",
    ""IgG-secreting Plasma Cells"",
    ""Plasma Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}",B cells,Plasma cells,IgA-secreting plasma cells,95,"The annotation results demonstrate a high level of scientific accuracy and a comprehensive understanding of the markers provided. Here's a detailed analysis:

1. **Correctness of the Annotations**: 
   - The identification of the cluster as **Plasma Cells** is well-supported by the presence of canonical plasma cell markers such as **TNFRSF17 (BCMA)**, **MZB1**, and **GPRC5D**. The inclusion of **CCR10**, which is associated with mucosal homing, further strengthens the annotation, especially given the tissue origin (human large intestine).
   - The sub-cell type annotation as **IgA-secreting Plasma Cells** is particularly well-justified, given the high expression of **IGHA1** and **IGHA2**, which are specific to IgA production. The mention of **IgG-secreting Plasma Cells** due to **IGHG1** and **IGHG3** expression is also accurate, though IgA is correctly emphasized as the dominant isotype in this context.
   - The annotation also correctly notes the presence of genes involved in protein secretion and ER function (e.g., **DERL3**, **TXNDC5**), which are characteristic of plasma cells due to their high antibody production activity.

2. **Balanced Consideration of Markers**:
   - The analysis does not overly rely on a single marker but instead considers a broad range of immunoglobulin genes (both heavy and light chains) and other supporting markers like **JCHAIN** and **MZB1**. This balanced approach ensures that the annotation is not skewed by any single gene.
   - The rank of markers is implicitly considered, as the analysis highlights the most prominent markers (e.g., immunoglobulin genes) first, which aligns with their likely higher expression levels.

3. **Comprehensive View of Cell Types**:
   - The annotation captures the general picture of the cell population by acknowledging the heterogeneity within the cluster (e.g., the presence of both IgA and IgG-secreting plasma cells). The inclusion of **Plasma Cells** as a broader category alongside the more specific sub-cell types ensures that the annotation is not overly narrow.
   - The absence of obvious misclassifications or oversights is notable. For example, the analysis correctly avoids conflating plasmablasts with mature plasma cells, given the strong secretion signature and mature plasma cell markers present.

4. **Minor Weaknesses**:
   - While the annotation is thorough, it could briefly mention the presence of **IGHM** (IgM heavy chain) as a minor isotype, which is noted in the marker list but not explicitly discussed in the sub-cell type analysis. This is a minor oversight but does not detract significantly from the overall quality.
   - The annotation could also provide a brief note on the functional implications of the identified cell types (e.g., the role of IgA in mucosal immunity), though this is more of a supplementary point.

Overall, the annotation is scientifically rigorous, well-balanced, and comprehensive, with only minor areas for improvement."
transit amplifying cell of large intestine,Proliferating Cells,"Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), Early Progenitor Cells",,50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash-preview,openrouter,large intestine,human,,"Final Annotation Agent: Okay, let's analyze this list of highly expressed genes from a single-cell cluster in human large intestine tissue to identify the cell type.

**Step 1: List the Key Functional Markers**

This list is overwhelmingly enriched for genes involved in cell cycle progression, DNA replication, and mitosis. Let's group some of the key functional markers:

*   **Cell Cycle Regulation and Mitosis:**
    *   `MKI67`: A well-established marker of proliferating cells, present during all active phases of the cell cycle (G1, S, G2, and mitosis) but absent from resting cells (G0). Its high expression is a strong indicator of cell division.
    *   `CDK1` (also known as CDC2): A key cyclin-dependent kinase that regulates progression through the cell cycle, particularly the G2/M transition.
    *   `CCNB2` (Cyclin B2): A regulatory protein that associates with CDK1 and is essential for mitotic entry.
    *   `PLK1` (Polo-like kinase 1): A crucial regulator of multiple mitotic events, including centrosome maturation, bipolar spindle formation, and cytokinesis.
    *   `AURKB` (Aurora kinase B): A key component of the chromosomal passenger complex, essential for chromosome alignment, segregation, and cytokinesis.
    *   `TTK` (also known as MPS1): A kinase involved in the spindle assembly checkpoint (SAC), ensuring proper chromosome segregation.
    *   `NEK2`: A kinase involved in centrosome separation and maturation.
    *   `CDC25C`: A phosphatase that activates CDK1, promoting entry into mitosis.
    *   `NCAPG` (Non-SMC condensin I complex subunit G): A component of the condensin complex, involved in chromosome condensation.
    *   `PIMREG`: Involved in cell cycle progression and proliferation.
    *   `CDCA3`, `CDCA5`: Cell division cycle associated proteins, involved in cell cycle regulation.
    *   `PKMYT1`: A kinase that inhibits CDK1, involved in cell cycle control.
    *   `GTSE1`: Involved in cell cycle regulation and DNA damage response.
    *   `OIP5`: Involved in cell cycle progression.
    *   `FOXM1`: A transcription factor that regulates the expression of many genes involved in cell cycle progression and mitosis. Its high expression is characteristic of proliferating cells.
    *   `SKA1`, `SKA3`: Components of the outer kinetochore, essential for proper chromosome segregation.
    *   `NUF2`, `SPC24`, `SPC25`: Components of the NDC80 complex, a key part of the kinetochore.
    *   `KIF2C`, `KIF15`, `KIF18B`: Kinesin motor proteins involved in spindle dynamics and chromosome movement during mitosis.
    *   `CKAP2L`: Cytoskeleton-associated protein, potentially involved in spindle organization.
    *   `DLGAP5`: A scaffolding protein involved in spindle organization and cytokinesis.
    *   `CEP55`: Involved in cytokinesis.
    *   `TROAP`: Involved in cytokinesis.
    *   `DIAPH3`: Involved in cytokinesis.
    *   `IQGAP3`: Involved in cell proliferation and migration.

*   **DNA Replication and Repair:**
    *   `RRM2`: Ribonucleotide reductase M2 subunit, essential for dNTP synthesis, required for DNA replication.
    *   `TOP2A` (DNA topoisomerase II alpha): Involved in resolving DNA tangles and supercoils during replication and mitosis.
    *   `PCLAF` (PCNA-associated factor): Interacts with PCNA, involved in DNA replication and repair.
    *   `MND1`: Involved in homologous recombination and DNA repair.
    *   `POLQ` (DNA polymerase theta): Involved in DNA repair pathways.
    *   `GINS2`: A component of the GINS complex, essential for the initiation and elongation of DNA replication.
    *   `RAD51AP1`: Involved in homologous recombination and DNA repair.
    *   `CDT1`: Involved in DNA replication initiation.
    *   `TK1` (Thymidine kinase 1): Involved in the salvage pathway of dNTP synthesis.
    *   `CDC45`: A component of the CMG helicase complex, essential for DNA replication initiation and elongation.
    *   `CCNA2` (Cyclin A2): Involved in both DNA replication (S phase) and mitotic entry (G2 phase).

*   **Centromere and Chromosome Structure:**
    *   `HJURP` (Holliday junction recognition protein): Involved in the deposition of the centromeric histone variant CENPA.
    *   `CENPA` (Centromere protein A): A histone variant that marks centromeres and is essential for kinetochore assembly.
    *   `ASPM` (Abnormal spindle-like microcephaly associated): Involved in spindle pole integrity and mitotic progression.

*   **Ubiquitination:**
    *   `UBE2C` (Ubiquitin-conjugating enzyme E2 C): Involved in the ubiquitination and degradation of mitotic regulators, crucial for timely cell cycle progression.

*   **Other:**
    *   `PBK` (also known as TOPK): A kinase involved in various cellular processes, including cell cycle progression and proliferation.
    *   `DEPDC1`: Involved in cell cycle progression and proliferation.
    *   `ZNF695`: A zinc finger protein, its specific role in this context is less clear but may be related to transcriptional regulation of cell cycle genes.

**Step 2: List the Key Cell Type Markers**

Based on the provided list, there are no specific markers for differentiated cell types of the large intestine (e.g., enterocytes, goblet cells, enteroendocrine cells, immune cells, stromal cells). The markers are overwhelmingly related to cell cycle and proliferation.

**Step 3: Cross-reference Known Databases**

Searching databases like the Human Protein Atlas, PanglaoDB, and reviewing scRNA-seq literature on the large intestine confirms that the genes listed are highly enriched in proliferating cell populations. Specifically, markers like `MKI67`, `TOP2A`, `CDK1`, `CCNB2`, `RRM2`, and many of the kinetochore and spindle-associated proteins are canonical markers of actively dividing cells across various tissues, including the intestinal epithelium.

**Step 4: Determine the Most Probable General Cell Type**

Given the extremely high expression of a large number of genes directly involved in DNA replication, cell cycle progression, and mitosis, the most probable general cell type is **Proliferating Cells**.

**Step 5: Identify the Top 3 Most Probable Sub Cell Types**

Within the context of the large intestine, proliferating cells are primarily found in the crypts of the epithelium. These proliferating cells include:

1.  **Intestinal Stem Cells (ISCs):** These are the primary self-renewing cells in the crypts, responsible for generating all epithelial lineages. They are highly proliferative.
2.  **Transit-Amplifying (TA) Cells:** These are daughter cells of ISCs that undergo a limited number of rapid divisions before differentiating into various epithelial cell types. They are also highly proliferative.
3.  **Early Progenitor Cells:** While ISCs and TA cells are the main proliferative populations, early progenitor cells committed to specific lineages might still be undergoing some division before terminal differentiation.

Based on the markers provided, it is difficult to definitively distinguish between ISCs and TA cells solely on this list, as both populations are highly proliferative and express many of these cell cycle genes. However, the sheer breadth and intensity of the proliferation signature suggest a population undergoing rapid division.

Ranking the most probable sub cell types:

1.  **Transit-Amplifying (TA) Cells:** TA cells are characterized by rapid and extensive proliferation to expand the cell pool before differentiation. The strong and broad expression of proliferation markers aligns well with this population's function.
2.  **Intestinal Stem Cells (ISCs):** ISCs are also highly proliferative, but they also express markers related to stemness and self-renewal, which are not explicitly present in this list. However, their proliferative nature means they would express many of these genes.
3.  **Early Progenitor Cells:** While proliferative, their division rate might be lower than TA cells, and they would likely start expressing some lineage-specific markers, which are absent here.

Therefore, the most likely subtype based on this marker list is **Transit-Amplifying (TA) Cells**.

**Step 6: Provide a Concise Summary of Your Analysis**

The provided list of highly expressed genes from a single-cell cluster in human large intestine tissue is overwhelmingly enriched for markers of cell cycle progression, DNA replication, and mitosis, including canonical proliferation markers like MKI67, CDK1, CCNB2, and TOP2A. There is a notable absence of markers specific to differentiated intestinal epithelial lineages or other cell types found in the large intestine. This strong proliferative signature indicates that the cluster represents actively dividing cells. In the context of the large intestine epithelium, the most probable general cell type is Proliferating Cells. Within this category, the top three most probable sub cell types are Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), and Early Progenitor Cells. Based on the extensive and rapid proliferative nature suggested by the marker list, Transit-Amplifying (TA) Cells are the most likely subtype.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""Proliferating Cells"",
  ""sub_cell_types"": [
    ""Transit-Amplifying (TA) Cells"",
    ""Intestinal Stem Cells (ISCs)"",
    ""Early Progenitor Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}",Epithelial cells,Transit-amplifying cells,Transit-amplifying (TA) cells,95,"The annotation results provided are scientifically accurate and well-justified, demonstrating a strong understanding of the markers and their relevance to cell cycle and proliferation. The analysis correctly identifies the cluster as proliferating cells, which is supported by the overwhelming presence of markers like MKI67, CDK1, CCNB2, and TOP2A. The annotation also appropriately considers the context of the human large intestine, narrowing down the likely sub-cell types to Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), and Early Progenitor Cells. 

Strengths:
1. **Comprehensive Marker Analysis**: The annotation thoroughly groups and explains the functional roles of the markers, covering cell cycle regulation, DNA replication, mitosis, and other relevant processes. This demonstrates a balanced consideration of multiple markers rather than over-focusing on a single one.
2. **Contextual Relevance**: The annotation correctly places the markers in the context of the large intestine, identifying the crypt as the likely location of these proliferating cells.
3. **Sub-Cell Type Differentiation**: The annotation logically ranks the sub-cell types, with TA cells being the most probable, followed by ISCs and early progenitors. This reflects an understanding of the hierarchy and proliferation rates in the intestinal epithelium.
4. **Validation**: The annotation mentions validation passed, indicating that the results were cross-referenced with known databases, adding credibility.

Weaknesses:
1. **Lack of Stemness Markers**: While the annotation mentions ISCs, it does not explicitly address the absence of stemness markers (e.g., LGR5, ASCL2) that could further distinguish ISCs from TA cells. This could be a minor oversight.
2. **Marker Rank Consideration**: The annotation does not explicitly discuss the rank or expression levels of the markers, which could provide additional insights into the dominance of certain pathways or cell states. For example, the order of markers might hint at specific phases of the cell cycle being more active.

Overall, the annotation provides a comprehensive and accurate view of the cell populations, with only minor areas for improvement."
